New Drug News

New Drug News

MULTAQ (Dronedarone) 400mg tablets from sanofi-aventis

Multaq

Profiles dronedarone, an antiarrhythmic agent designed to reduce risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter.

Aplenzin

Aplenzin

Profiles the long-acting bupropion formulation used for major depressive disorder.

FERAHEME (Ferumoxytol) 30mg/mL injection by AMAG Pharmaceuticals

Feraheme

Profiles the colloidal iron agent indicated for iron deficiency anemia in adult patients with chronic kidney disease.

EMBEDA (morphine sulfate and naltrexone HCl) extended-release cpasules from King Pharmaceuticals

Embeda

Profiles Embeda, the morphine pain reliever formulated to prevent abuse of the drug.

Nucynta available for moderate to severe acute pain

Nucynta

Profiles the Opioid used to treat advanced prostate cancer moderate to severe acute pain in patients ≥ 18 years of age.

RYZOLT (Tramadol) 100mg, 200mg, 300mg ext-rel tablets by Purdue Pharma

Ryzolt

Profiles the Opioid used to treat moderate to moderately severe chronic pain.

Degarelix approved for advanced prostate cancer

Degarelix

Profiles the GnRH receptor antagonist used to treat advanced prostate cancer.

AFINITOR (Everolimus) 5mg, 10mg tablets by Novartis

Afinitor

Profiles the mTOR kinase inhibitor antineoplastic agent used to treat advanced kidney cancer.

ULORIC (Febuxostat) 40mg, 80mg tablets by Takeda

Uloric

Profiles the xanthine oxidase inhibitor indicated for chronic management of hyperuricemia in patients with gout.

SAVELLA (Milnacipran) 12.5mg, 25mg, 50mg, 100mg tablets by Forest and Cypress

Savella

Profiles the new serotonin and norepinephrine reuptake inhibitor indicated for fibromyalgia.

Next post in New Drug News